DENVER, Colo., Aug 12, 2025 (247marketnews.com)- 180 Life Sciences (NASDAQ:ATNF) reported that it currently holds a total of 82,186 Ethereum (ETH) at an average acquisition price of $3,806.71. These holdings are valued at approximately $349 million. In addition to its ETH position, ETHZilla holds roughly $238 million in USD cash equivalents.
“At ETHZilla we have put over $350 million in capital to work since the PIPE transaction we completed last week, and have executed on our strategy to rapidly build a differentiated Ethereum treasury vehicle,” stated McAndrew Rudisill, Executive Chairman of the Company.
As of August 11, 2025 (except where noted), key ETHZilla metrics include:
- Total ETH & ETH Equivalents Held: 82,186
- ETH & ETH Equivalents in USD: ~$349 million
- USD Cash Equivalents: ~$238 million
- Shares Outstanding (as of August 5, 2025):032 million
ETHZilla’s recently acquired ETH is expected to be held long-term and staked through Electric Capital’s proprietary Ethereum network strategies to generate on-chain yield. The Company plans to provide ongoing updates on its treasury strategy and yield generation initiatives via public announcements and regulatory filings.
The post ETHZilla Unleashes $349M Ethereum War Chest, Solidifies Position as Premier On-Chain Treasury Powerhouse appeared first on 24/7 MarketNews.